Kalincik, Thomas, Cutter, Gary, Prat, Alexandre, Lugaresi, Alessandra, Grand'Maison, Francois, Grammond, Pierre, Hupperts, Raymond, Oreja-Guevara, Celia, Boz, Cavit, Pucci, Eugenio, Bergamaschi, Roberto, Lechner-Scott, Jeannette, Spelman, Tim, Alroughani, Raed, Van Pesch, Vincent, Iuliano, Gerardo, Fernandez-Bolaños, Ricardo, Ramo, Cristina, Terzi, Murat, Slee, Mark, Spitaleri, Daniele, Verheul, Freek, Cristiano, Edgardo, Jokubaitis, Vilija, Sánchez-Menoyo, José Luis, Fiol, Marcela, Gray, Orla, Cabrera-Gomez, Jose Antonio, Barnett, Michael, Butzkueven, Helmut, Havrdova, Eva, Horakova, Dana, Trojano, Maria, Izquierdo, Guillermo, Girard, Marc, Duquette, Pierre. Oxford University Press; 2015. Defining reliable disability outcomes in multiple sclerosis.

Kalincik, Tomas, Buzzard, Katherine, Oreja-Guevara, Celia, Boz, Cavit, Hupperts, Raymond, Petersen, Thor, Giuliani, Giorgop, Iuliano, Gerardo, Lechner-Scott, Jeannette, Barnett, Michael, Bergamaschi, Roberto, Van Pesch, Vincent, Jokubaitis, Vilija, Amato, Maria Pia, van Munster, Erik, Fernandez-Bolanos, Ricardo, Verheul, Freek, Fiol, Marcela, Cristiano, Edgardo, Slee, Mark, Rio, Maria Edite, Spitaleri, Daniele, Alroughani, Raed, Trojano, Maria, Gray, Orla, Saladino, Maria Laura, Flechter, Sholmo, Herbert, Joseph, Cabrera-Gomez, Jose Antonio, Vella, Norbert, Paine, Mark, Shaw, Cameron, Moore, Fraser, Vucic, Steve, Duquette, Pierre, Savino, Aldo, Singhal, Bhim, Petkovska-Boskova, Tatjana, Parratt, John, Sirbu, Carmen-Adella, Rozsa, Csilla, Liew, Danny, Butzkueven, Helmut, , Izquierdo, Guillermo, Girard, Marc, Lugaresi, Alessandra, Grammond, Pierre, Grand'Maison, Francois. Sage Publications; 2014. Risk of relapse phenotype recurrence in multiple sclerosis.

Patsopoulos, Nikolaos A., de Bakker, Paul I. W., Kappos, Ludwig, Miller, David, Montalbán, Javier, Polman, Chris H., Freedman, Mark S., Hartung, Hans-Peter, Arnason, Barry G. W., Comi, Giancarlo, Cook, Stuart, Filippi, Massimo, Esposito, Federica, Goodin, Douglas S., Jeffery, Douglas, O'Connor, Paul, Ebers, George C., Langdon, Dawn, Reder, Anthony T., Traboulsee, Anthony, Zipp, Frauke, Schimrigk, Sebastian, Hillert, Jan, Reischl, Joachim, Bahlo, Melanie, Booth, David R., Broadley, Simon, Brown, Matthew A., Browning, Brian L., Browning, Sharon R., Butzkueven, Helmut, Carroll, William M., Chapman, Caron, Foote, Simon J., Lehr, Stephan, Griffiths, Lyn, Kermode, Allan G., Kilpatrick, Trevor J., Lechner-Scott, Jeannette, Marriott, Mark, Mason, Deborah, Moscato, Pablo, Heard, Robert N., Pender, Michael P., Perreau, Victoria M., Bauer, David, Perera, Devindri, Rubio, Justin P., Scott, Rodney J., Slee, Mark, Stankovich, Jim, Stewart, Graeme J., Taylor, Bruce V., Tubridy, Niall, Willoughby, Ernest, Wiley, James, Heubach, Jürgen, Matthews, Paul, Boneschi, Filippo M., Compston, Alastair, Haines, Jonathan, Hauser, Stephen L., McCauley, Jacob, Ivinson, Adrian, Oksenberg, Jorge R., Pericak-Vance, Margaret, Sawcer, Stephen J., Sandbrink, Rupert, De Jager, Philip L., Hafler, David A., Pohl, Christoph, Edan, Gilles. John Wiley & Sons; 2011. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.

Broadley, Simon A., Barnett, Michael H., Marriott, Mark, Mason, Deborah F., Parratt, John, Reddel, Stephen W., Shaw, Cameron P., Slee, Mark, Spies, Judith, Taylor, Bruce V., Carroll, William M., Kilpatrick, Trevor J., Boggild, Mike, King, John, McCombe, Pamela A., Pollard, John D., Willoughby, Ernest, Brew, Bruce J., Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G., Lechner-Scott, Jeannette, Macdonell, Richard A. L.. Elsevier; 2014. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies.

Jokubaitis, Vilija G., Li, Vivien, Barnett, Michael, Grand'Maison, Francois, Trojano, Maria, Slee, Mark, Giuliani, Giorgio, Shaw, Cameron, Boz, Cavit, Spitaleri, Daniele L. A., Verheul, Freek, Haartsen, Jodi, Kalincik, Tomas, Liew, Danny, Butzkueven, Helmut, Izquierdo, Guillermo, Hodgkinson, Suzanne, Alroughani, Raed, Lechner-Scott, Jeannette, Lugaresi, Alessandra, Duquette, Pierre, Girard, Marc. Lippincott Williams & Wilkins; 2014. Fingolimod after natalizumab and the risk of short-term relapse.

Gu, Ben J., Field, Judith, Butzkueven, Helmut, Gresle, Melissa, Laws, Simon M., Petrou, Steven, Hoffjan, Sabine, Akkad, Denis A., Graham, Colin A., Hawkins, Stanley, Glaser, Anna, Bedri, Sahl Khalid, Dutertre, Sébastien, Hillert, Jan, Matute, Carlos, Antiguedad, Alfredo, Wiley, James S., Ou, Amber, Kilpatrick, Trevor J., Lechner-Scott, Jeannette, Scott, Rodney, Lea, Rodney, Taylor, Bruce V., Stankovich, Jim. Oxford University Press; 2015. A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis.

Shahijanian, Fernando, Parnell, Grant P., Baxter, Alan, Kermode, Allan, Carroll, William, Butzkueven, Helmut, Booth, David, Stewart, Graeme, Vucic, Steve, Wiley, James, Field, Judith, Tajouri, Lotti, McKay, Fiona C., Griffiths, Lyn, Barnett, Michael, Scott, Rodney, Lechner-Scott, Jeannette, Moscato, Pablo, Broadley, Simon, Slee, Mark, Kilpatrick, Trevor, Taylor, Bruce, Charlesworth, Jac, Gatt, Prudence N., Brown, Matt, Mason, Deborah, Stewart, Graeme J., Booth, David R., Shojoei, Maryam, O'Connor, Kate S., Schibeci, Stephen D., Brilot, Fabienne, Liddle, Christopher, Batten, Marcel. Oxford University Press; 2014. The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cells.

Hughes, Stella E., Spelman, Tim, Grammond, Pierre, Oreja-Guevara, Celia, Hupperts, Raymond, Bergamaschi, Roberto, Giuliani, Giorgio, Lechner-Scott, Jeannette, Barnett, Michael, Edite Rio, Maria, Van Pesch, Vincent, Amato, Maria Pia, Gray, Orla M., Iuliano, Gerardo, Slee, Mark, Verheul, Freek, Cristiano, Edgardo, Fernández-Bolaños, Ricardo, Poehlau, Dieter, Saladino, Maria Laura, Deri, Norma, Cabrera-Gomez, Jose, Vella, Norbert, Boz, Cavit, Herbert, Joseph, Skromne, Eli, Savino, Aldo, Shaw, Cameron, Moore, Fraser, Vucic, Steve, Petkovska-Boskova, Tatjana, McDonnell, Gavin, Hawkins, Stanley, Kee, Frank, Trojano, Maria, Butzkueven, Helmut, Lugaresi, Alessandra, Izquierdo, Guillermo, Duquette, Pierre, Girard, Marc, Grand'Maison, Francois. Sage; 2014. Predictors and dynamics of postpartum relapses in women with multiple sclerosis.

Bukhari, Wajih, Prain, Kerri M., Blum, Stefan, Boggild, Mike, Boundy, Karyn, Brew, Bruce J., Brown, Matthew, Brownlee, Wallace J., Butzkueven, Helmut, Carroll, William M., Chen, Celia, Coulthard, Alan, Waters, Patrick, Dale, Russell C., Woodhall, Mark, Lechner-Scott, Jeannette, O'Gorman, Cullen M., Clarke, Laura, Silvestrini, Roger A., Bundell, Christine S., Abernethy, David, Bhuta, Sandeep. BMJ Group; 2017. Incidence and prevalence of NMOSD in Australia and New Zealand.

Tao, Chunrong, Simpson, Steve, Duquette, Pierre, Girard, Marc, Grand'Maison, Francois, Grammond, Pierre, Alroughani, Raed, Terzi, Murat, Oreja-Guevara, Celia, Sajedi, Seyed Aidin, Iuliano, Gerardo, Sola, Patrizia, van der Mei, Ingrid, Lechner-Scott, Jeannette, Van Pesch, Vincent, Pucci, Eugenio, Bergamaschi, Roberto, Barnett, Michael, Ramo, Cristina, Singhal, Bhim, Spitaleri, Daniele L. A., Slee, Mark, Verheul, Freek, Blizzard, Leigh, Fernández Bolaños, Ricardo, Amato, Maria Pia, Cristiano, Edgardo, Granella, Franco, Hodgkinson, Suzanne, Fiol, Marcela, Gray, Orla, McCombe, Pamela, Saladino, Maria Laura, Sánchez Menoyo, José Luis, Havrdova, Eva, Shuey, Neil, Vucic, Steve, Shaw, Cameron, Deri, Norma, Arruda, Walter Oleschko, Butzkueven, Helmut, Spelman, Tim, Taylor, Bruce V., Horakova, Dana, Shaygannejad, Vahid, Lugaresi, Alessandra, Izquierdo, Guillermo, Trojano, Maria. BMJ Group; 2016. Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.

Spelman, Tim, Gray, Orla, Boz, Cavit, Verheul, Freek, Oreja-Guevara, Celia, Barnett, Michael, Grand'Maison, Francois, Rio, Maria Edite, Lechner-Scott, Jeannette, Van Pesch, Vincent, Bolanos, Ricardo Fernandez, Flechter, Shlomo, Trojano, Maria, Braber-Moerland, Leontien Den, Iuliano, Gerardo, Amato, Maria Pia, Slee, Mark, Cristiano, Edgardo, Saladino, Maria Laura, Paine, Mark, Vella, Norbert, Kasa, Krisztian, Deri, N, Petersen, Thor, Herbert, Joseph, Moore, Fraser, Petkovska-Boskova, Tatjana, Alroughani, Raed, Savino, Aldo, Shaw, Cameron, Vucic, Steve, Santiago, Vetere, Bacile, Elizabeth Alejandra, Skromne, Eli, Izquierdo, Guillermo, Poehlau, Dieter, Cabrera-Gomez, Jose Antonio, Lucas, Robyn, Butzkueven, Helmut, Lugaresi, Alessandra, Hupperts, Raymond, Bergamaschi, Roberto, Duquette, Pierre, Giuliani, Giorgio. John Wiley and Sons; 2014. Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.

Broadley, Simon A., Barnett, Michael H., Marriott, Mark, Mason, Deborah F., Parratt, John, Reddel, Stephen W., Shaw, Cameron P., Slee, Mark, Spies, Judith M., Taylor, Bruce V., Carroll, William M., Kilpatrick, Trevor J., Boggild, Mike, King, John, McCombe, Pamela A., Pollard, John D., Willoughby, Ernest, Brew, Bruce J., Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G., Lechner-Scott, Jeannette, Macdonell, Richard A. L.. Australasian Medical Publishing Company Pty. Ltd.; 2015. A new era in the treatment of multiple sclerosis.

Lorscheider, Johannes, Buzzard, Katherine, Prat, Alexandre, Lugaresi, Alessandra, Grand'Maison, François, Grammond, Pierre, Hupperts, Raymond, Alroughani, Raed, Sola, Patrizia, Boz, Cavit, Pucci, Eugenio, Lechner-Scott, Jeanette, Jokubaitis, Vilija, Bergamaschi, Roberto, Oreja-Guevara, Celia, Iuliano, Gerardo, Van Pesch, Vincent, Granella, Franco, Ramo-Tello, Cristina, Spitaleri, Daniele, Petersen, Thor, Slee, Mark, Verheul, Freek, Spelman, Tim, Ampapa, Radek, Amato, Maria Pia, McCombe, Pamela, Vucic, Steve, Sánchez Menoyo, José Luis, Cristiano, Edgardo, Barnett, Michael H., Hodgkinson, Suzanne, Olascoaga, Javier, Laura Saladino, Maria, Havrdova, Eva, Gray, Orla, Shaw, Cameron, Moore, Fraser, Butzkueven, Helmut, Kalincik, Tomas, Horakova, Dana, Trojano, Maria, Izquierdo, Guillermo, Girard, Marc, Duquette, Pierre. Oxford University Press; 2016. Defining secondary progressive multiple sclerosis.

Kister, Ilya, Spelman, Tim, Iuliano, Gerardo, Hupperts, Raymond, Pucci, Eugenio, Trojano, Maria, Butzkueven, Helmut, , Alroughani, Raed, Lechner-Scott, Jeannette, Duquette, Pierre, Grand'Maison, Francois, Slee, Mark, Lugaresi, Alessandra, Barnett, Michael, Grammond, Pierre. B M J Group; 2016. Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study.

Broadley, Simon A., Barnett, Michael H., Marriott, Mark, Mason, Deborah F., Parratt, John, Reddel, Stephen W., Shaw, Cameron P., Slee, Mark, Spies, Judith, Taylor, Bruce V., Carroll, William M., Kilpatrick, Trevor J., Boggild, Mike, King, John, McCombe, Pamela A., Pollard, John D., Willoughby, Ernest, Brew, Bruce J., Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G., Lechner-Scott, Jeannette, Macdonell, Richard A. L.. Elsevier; 2014. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations.

Lill, Christina M., Liu, Tian, Blaschke, Paul, Winkelmann, Alexander, Gerdes, Lisa-Ann, Luessi, Felix, Fernadez, Oscar, Izquierdo, Guillermo, Antiguedad, Alfredo, Hoffjan, Sabine, Cournu-Rebeix, Isabelle, Gromoller, Silvana, Schjeide, Brit-Maren M., Faber, Hans, Liebsch, Maria, Meissner, Esther, Chanvillard, Coralie, Touze, Emmauel, Pico, Fernando, Corcia, Philippe, Bahlo, Melanie, Booth, David R., Broadley, Simon, Roehr, Johannes T., Brown, Matthew A., Browning, Brian L., Browning, Sharon R., Butzkueven, Helmut, Carroll, William M., Cox, Mathew B., Chapman, Caron, Clarke, Glynnis, Danoy, Patrick, Drysdale, Karen, Akkad, Denis A., Field, Judith, Foote, Simon J., Greer, Judith M., Griffiths, Lyn R., Hadler, Johanna, Jensen, Cathy J., Johnson, Laura J., Kermode, Allan G., Heard, Robert N., Kilpatrick, Trevor J., Damotte, Vincent, Lechner-Scott, Jeanette, Marriott, Mark, Mason, Deborah, Moscato, Pablo, Pender, Michael P., Perreau, Victoria M., Rubio, Justin P., Scott, Rodney J., Slee, Mark, Stankovich, Jim, Alcina, Antonio, Stewart, Graeme J., Tajouri, Lofti, Taylor, Bruce V., Wiley, James, Wilkins, Ella J., Dörner, Thomas, Steinhagen-Thiessen, Elisabeth, Baeckman, Lars, Heekeren, Hauke R., Li, Shu-Chen, Ortiz, Miguel A., Lindenberger, Ulman, Chan, Andrew, Hartung, Hans-Peter, Aktas, Orhan, Lohse, Peter, Kümpfel, Tania, Kubisch, Christian, Epplen, Joerg T., Zettl, Uwe K., Fontaine, Bertrand, Arroyo, Rafa, Vandenbroeck, Koen, Matesanz, Fuencisla, Urcelay, Elena, Bertram, Lars, Zipp, Frauke, Lopez de Lapuente, Aitzkoa. BMJ Group; 2012. Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects.

Kalincik, Tomas, Jokubaitis, Vilija, Grand'Maison, Francois, Pucci, Eugenio, Van Pesch, Vincent, Boz, Cavit, Iuliano, Gerardo, Fernandez-Bolanos, Ricardo, Flechter, Shlomo, Spitaleri, Daniele, Cristiano, Edgardo, Verheul, Ferek, Izquierdo, Guillermo, Lechner-Scott, Jeannette, Amato, Maria Pia, Cabrera-Gomez, Jose Antonio, Saladino, Maria Laura, Slee, Mark, Moore, Fraser, Gray, Orla, Paine, Mark, Barnett, Michael, Havrdova, Eva, Duquette, Pierre, Horakova, Dana, Spelman, Timothy, Trojano, Maria, Butzkueven, Helmut, , , Girard, Marc, Grammond, Pierre, Lugaresi, Alessandra, Oreja-Guevara, Celia, Bergamaschi, Roberto, Hupperts, Raymond. Sage; 2014. Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis.

Kalincik, Tomas, Jokubaitis, Vilja, Duquette, Pierre, Grammond, Pierre, Solaro, Claudio, Grand'Maison, Francois, Hupperts, Raymond, Prevost, Julie, Sola, Patrizia, Ferraro, Diana, Terzi, Murat, Butler, Ernest, Spelman, Tim, Slee, Mark, Kermode, Allan, Fabis-Pedrini, Marzena, McCombe, Pamela, Barnett, Michael, Shaw, Cameron, Hodgkinson, Suzanne, Butzkueven, Helmut, MSBase Study Group,, Horakova, Dana, Havrdova, Eva, Trojano, Maria, Lechner-Scott, Jeannette, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc. Sage; 2018. Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis.

Hughes, Jordana, Jokubaitis, Vilija, Lugaresi, Alessandra, Hupperts, Raymond, Izquierdo, Guillermo, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grand'Maison, Francois, Grammond, Pierre, Sola, Patrizia, Ferraro, Diana, Ramo-Tello, Cristina, Trojano, Maria, Slee, Mark, Shaygannejad, Vahid, Boz, Cavit, Lechner-Scott, Jeanette, Van Pesch, Vincent, Pucci, Eugenio, Solaro, Claudio, Verheul, Freek, Terzi, Murat, Granella, Franco, Spitaleri, Daniele, Alroughani, Raed, Jun, Jae-Kwan, Fambiatos, Adam, Van der Walt, Anneke, Butzkueven, Helmut, Kalincik, Tomas. American Medical Association (AMA); 2018. Association of inflammation and disability accrual in patients with progressive-onset multiple sclerosis.

Broadley, Simon A., Barnett, Michael H., Marriott, Mark, Mason, Deborah F., Parratt, John, Reddel, Stephen W., Shaw, Cameron P., Slee, Mark, Spies, Judith, Taylor, Bruce V., Carroll, William M., Kilpatrick, Trevor J., Boggild, Mike, King, John, McCombe, Pamela A., Pollard, John D., Willoughby, Ernest, Brew, Bruce J., Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G., Lechner-Scott, Jeannette, Macdonell, Richard A. L.. Elsevier; 2014. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy.

Kunchok, Amy, Malpas, Charles, Ozakbas, Serkan, Olascoaga, Javier, Simo, Magdolna, Granella, Franco, Patti, Francesco, McCombe, Pamela, Csepany, Tundle, Singhal, Bhim, Bergamaschi, Roberto, Fragoso, Yara, Nytrova, Petra, Al-Harbi, Talal, Turkoglu, Recai, Lechner-Scott, Jeannette, Laureys, Guy, Oreja-Guevara, Celia, Pucci, Eugenio, Sola, Patrizia, Ferraro, Diana, Altintas, Ayse, Soysala, Aysun, Havrdova, Eva Kubala, Vucic, Steve, Grand'Maison, Francois, Izquierdo, Guillermo, Eichau, Sara, Lugaresi, Alessandra, Onofrj, Marco, Trojano, Maria, Marriott, Mark, Butzkueven, Helmut, Kister, Ilya, Alroughani, Raed, Kalincik, Tomas, Terzi, Murat, Yamout, Bassem, Hor, Jyh Yung, Karabudak, Rana, Boz, Cavit. Elsevier; 2020. Clinical and therapeutic predictors of disease outcomes in AQP4-IgG + neuromyelitis optica spectrum disorder.

Jokubaitis, Vilija G., Spelman, Tim, Cabrera-Gomez, José, Oreja-Guevara, Celia, Boz, Cavit, Giuliani, Giorgio, Fernández-Bolaños, Ricardo, Iuliano, Gerardo, Lechner-Scott, Jeannette, Verheul, Freek, van Pesch, Vincent, Petkovska-Boskova, Tatjana, Kalincik, Tomas, Fiol, Marcela, Moore, Fraser, Cristiano, Edgardo, Alroughani, Raed, Bergamaschi, Roberto, Barnett, Michael, Slee, Mark, Vella, Norbet, Herbert, Joseph, Shaw, Cameron, Izquierdo, Guillermo, Saladino, Maria Laura, Amato, Maria Pia, Liew, Danny, Paolicelli, Damiano, Butzkueven, Helmut, Trojano, Maria, Grand'Maison, François, Duquette, Pierre, Girard, Marc, Lugaresi, Alessandra, Grammond, Pierre, Hupperts, Raymond. John Wiley & Sons; 2015. Predictors of disability worsening in clinically isolated syndrome.

Ribbons, Karen Ann, McElduff, Patrick, Oreja-Guevara, Celia, Petersen, Thor, Bergamaschi, Roberto, Giuliani, Giorgio, Barnett, Michael, van Pesch, Vincent, Amato, Maria-Pia, Iuliano, Gerardo, Fiol, Marcela, Slee, Mark, Boz, Cavit, Verheul, Freek, Cristiano, Edgardo, Fernandez-Bolanos, Ricardo, Saladino, Maria-Laura, Rio, Maria Edite, Cabrera-Gomez, Jose, Butzkueven, Helmut, van Munster, Erik, Braber-Moerland, Leontien Den, Spitaleri, Daniele La, Trojano, Maria, Lugaresi, Alessandra, Shaygannejad, Vahid, Gray, Orla, Deri, Norma, Alroughani, Raed, Lechner-Scott, Jeannette, Izquierdo, Guillermo, Duquette, Pierre, Girard, Marc, Grand'Maison, Francois, Hupperts, Raymond, Grammond, Pierre. Public Library of Science (PLoS); 2015. Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS.

Field, Judith, Shahijanian, Fernando, Butzkueven, Helmut, Booth, David, Baxter, Alan, Kermode, Allan G., Taylor, Bruce, Booth, David R., Mason, Deborah, Stewart, Graeme J., Butzkueven, Helmut, Charlesworth, Jac, Schibeci, Stephen, Wiley, James, Lechner-Scott, Jeannette, Field, Judith, Tajouri, Lotti, Griffiths, Lyn, Slee, Mark, Brown, Matthew A., Moscato, Pablo, Scott, Rodney J., Broadley, Simon, Johnson, Laura, Vucic, Steve, Kilpatrick, Trevor, Carroll, William M., Gresle, Melissa, Laverick, Louise, Parnell, Grant, Stewart, Graeme, McKay, Fiona, Kilpatrick, Trevor. Public Library of Science (PLOS); 2015. The MS risk allele of CD40 is associated with reduced cell-membrane bound expression in antigen presenting cells: implications for gene function.

Spelman, Timothy, Kalincik, Tomas, Grand-Maison, Francois, Izquierdo, Guillermo, Grammond, Pierre, Duquette, Pierre, Lugaresi, Alessandra, Lechner-Scott, Jeannette, Oreja-Guevara, Celia, Hupperts, Raymond, Petersen, Thor, Barnett, Michael, Zhang, Annie, Trojano, Maria, Butzkueven, Helmut, , Pellegrini, Fabio, Wiendl, Heinz, Kappos, Ludwig, Tsvetkova, Larisa, Belachew, Shibeshih, Hyde, Robert, Verheul, Freek. John Wiley & Sons; 2015. Comparative efficacy of switching to natalizumab in active multiple sclerosis.

Jokubaitis, Vilija G., Spelman, Tim, Lechner-Scott, Jeannette, Barnett, Michael, Shaw, Cameron, Vucic, Steve, Liew, Danny, Butzkueven, Helmut, Slee, Mark, Australian MSBase Study Group. Public Library of Science; 2013. The Australian Multiple Sclerosis (MS) Immunotherapy Study: a prospective, multicentre study of drug utilisation using the MSBase platform.

Yan, Jun, Liu, Jia, Mason, Deborah, Griffiths, Lyn, Moscato, Pablo, Slee, Mark, Taylor, Bruce, Wiley, James, Field, Judith, Butzkueven, Helmut, Kilpatrick, Trevor J., Csurhes, Peter A., Lin, Clement Yihao, Pender, Michael P., McCombe, Pamela A., Greer, Judith M., Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZGene),, Scott, Rodney J., Lechner-Scott, Jeannette, Brown, Matthew A., Booth, David R., Stewart, Graeme J., Broadley, Simon. MDPIAG; 2012. Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis.

Wang, Joanne H., Pappas, Derek, Hauser, Stephen L., Baranzini, Sergio E., Oksenberg, Jorge R., Bahlo, Melanie, Booth, David R., Broadley, Simon A., Brown, Matthew A., Foote, Simon J., Griffiths, Lyn R., Kilpatrick, Trevor J., De Jager, Philip L., Lechner-Scott, Jeannette, Moscato, Pablo, Perreau, Victoria M., Rubio, Justin P., Scott, Rodney J., Stankovich, Jim, Stewart, Graeme J., Taylor, Bruce V., Wiley, James, Danoy, Patrick, Pelletier, Daniel, Butzkueven, Helmut, Slee, Mark, Greer, Judith, Kermode, Allan, Carroll, William, de Bakker, Paul I., Kappos, Ludwig, Polman, Chris H., Chibnik, Lori B., Hafler, David A., Matthews, Paul M.. BioMed Central; 2011. Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data.

Ritchie, Matthew E., Ruijie, Liu, Kilpatrick, Trevor J., Lechner-Scott, Jeannette, Moscato, Pablo, Perreau, Victoria M., Rubio, Justin P., Scott, Rodney J., Stankovich, Jim, Stewart, Graeme J., Taylor, Bruce V., Wiley, James, Carvalho, Benilton S., Booth, David R., Clarke, Glynnis, Cox, Mathew B., Csurhes, Peter A., Danoy, Patrick, Dickinson, Joanne L., Drysdale, Karen, Field, Judith, Greer, Judith M., Griffiths, Lyn R., Irizarry, Rafael A., Guru, Preethi, Hadler, Johanna, Hoban, Ella, McMorran, Brendan J., Jensen, Cathy J., Johnson, Laura J., McCallum, Ruth, Merriman, Marilyn, Merriman, Tony, Polanowski, Andrea, Bahlo, Melanie, Pryce, Karena, Tajouri, Lotfi, Whittock, Lucy, Wilkins, Ella J., Browning, Brian L., Browning, Sharon R., Perera, Devindri, Butzkueven, Helmut, Carroll, William M., Chapman, Caron, Booth, David R., Kermode, Allan G., Marriott, Mark, Mason, Deborah, Heard, Robert N., Pender, Michael P., Slee, Mark, Tubridy, Niall, Willoughby, Ernest, Broadley, Simon A., Brown, Matthew A., Foote, Simon J., Griffiths, Lyn R.. BioMed Central; 2011. Comparing genotyping algorithms for Illumina's Infinium whole-genome SNP BeadChips.

Ma, Gerry Z. M., Stankovich, Jim, Browning, Sharon R., Butzkueven, Helmut, Carroll, William M., Danoy, Patrick, Foote, Simon J., Griffiths, Lyn, Heard, Robert N., Kermode, Allan G., Lechner-Scott, Jeannette, Moscato, Pablo, Kilpatrick, Trevor J., Perreau, Victoria M., Scott, Rodney J., Slee, Mark, Stewart, Graeme J., Taylor, Bruce V., Wiley, James, Stankovich, Jim, Binder, Michele D., Field, Judith, Bahlo, Melanie, Booth, David R., Broadley, Simon, Brown, Matthew A., Browning, Brian L.. Public Library of Science; 2011. Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibility.

Jensen, Cathy J., Stankovich, Jim, Field, Judith, Danoy, Patrick, Brown, Matthew A., The Australian and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), Lechner-Scott, Jeanette, Moscato, Pablo, Scott, Rodney J., Rubio, Justin P,, Butzkueven, Helmut, Van der Walt, Anneke, Bahlo, Melanie, Taylor, Bruce V,, van der Mei, Ingrid A. F., Foote, Simon J., Kilpatrick, Trevor J,, Johnson, Laura J., Wilkins, Ella. Public Library of Science; 2010. Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients.

Field, Judith, Browning, Sharon R., Lechner-Scott, Jeanette, Moscato, Pablo, Scott, Rodney J., Stewart, Graeme J., Kilpatrick, Trevor J., Foote, Simon J., Bahlo, Melanie, Butzkueven, Helmut, Wiley, James, Booth, David R., Johnson, Laura J., Taylor, Bruce V., Brown, Matthew A., Rubio, Justin P., Stankovich, Jim, Danoy, Patrick, Varney, Michael D,, Tait, Brian D., Kaushal, S. Gandhi, Charlesworth, Jac C., Heard, Robert N., The Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene). Public Library of Science; 2010. A polymorphism in the HLA-DPB1 gene is associated with susceptibility to multiple sclerosis.

Maltby, Vicki E., Lea, Rodney A., Burnard, Sean, Xavier, Alexandre, Van Cao, Thao, White, Nicole, Kennedy, Daniel, Groen, Kira, Sanders, Katherine A., Seeto, Rebecca, Bray, Samara, Gresle, Melissa, Laverick, Louise, Butzkueven, Helmut, Scott, Rodney J., Lechner-Scott, Jeannette. Nature Publishing Group; 2020. Epigenetic differences at the HTR2A locus in progressive multiple sclerosis patients.

Lizak, Nathaniel, Hodgkinson, Suzanne, Barnett, Michael H., Parratt, John, Butzkueven, Helmut, Jack, Dominic, Fabris, Jessica, Kalincik, Tomas, Butler, Ernest, Lechner-Scott, Jeannette, Slee, Mark, McCombe, Pamela Ann, Shaw, Cameron, Skibina, Olga, Vucic, Steve, Shuey, Neil. Sage; 2021. Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: an MSBase registry substudy.

Yam, Charmaine, Merlo, Daniel, Butzkueven, Helmut, van der Walt, Anneke, Stankovich, Jim, Darby, David, Gresle, Melissa, Kalincik, Tomas, Kilpatrick, Trevor J., Lechner-Scott, Jeanette, Taylor, Bruce, Barnett, Michael. Elsevier; 2020. The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosis.